Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

iCAD vs. R2

This article was originally published in The Gray Sheet

Executive Summary

R2 ImageChecker mammography system infringes Scanis, Inc. '637 patent, July 1 suit filed by Scanis and iCAD, Inc. alleges. According to the suit, the Scanis technology dates back to 1989 when the company (then Sterometrix) created the first computer-aided detection system for breast cancer, four years before R2 was founded. According to R2, however, the '637 patent is invalid, and the iCAD/Scanis suit is merely a "diversionary tactic" intended to deflect attention from R2's October 2002 suit against iCAD, regarding three separate cancer detection patents...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018661

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel